Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - rivastigmine hydrogen tartrate, quantity: 2.4 mg - capsule - excipient ingredients: titanium dioxide; stearic acid; iron oxide yellow; maize starch; gelatin; microcrystalline cellulose; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - rivastigmine hydrogen tartrate, quantity: 7.2 mg - capsule - excipient ingredients: iron oxide yellow; stearic acid; microcrystalline cellulose; titanium dioxide; maize starch; iron oxide red; gelatin; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - rivastigmine hydrogen tartrate, quantity: 7.2 mg - capsule - excipient ingredients: gelatin; iron oxide yellow; iron oxide red; microcrystalline cellulose; maize starch; titanium dioxide; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type

Австралия - английский - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivastigmine hydrogen tartrate, quantity: 9.6 mg (equivalent: rivastigmine, qty 6 mg) - capsule, hard - excipient ingredients: iron oxide red; magnesium stearate; microcrystalline cellulose; titanium dioxide; colloidal anhydrous silica; iron oxide yellow; gelatin; hypromellose; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; allura red ac; povidone; sodium hydroxide - rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivastigmine hydrogen tartrate, quantity: 7.2 mg (equivalent: rivastigmine, qty 4.5 mg) - capsule, hard - excipient ingredients: sodium lauryl sulfate; titanium dioxide; iron oxide red; magnesium stearate; hypromellose; gelatin; colloidal anhydrous silica; iron oxide yellow; microcrystalline cellulose; propylene glycol; ethanol; isopropyl alcohol; shellac; povidone; tert-butyl alcohol; sodium hydroxide - rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivastigmine hydrogen tartrate, quantity: 4.8 mg (equivalent: rivastigmine, qty 3 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; hypromellose; iron oxide yellow; sodium lauryl sulfate; sunset yellow fcf; magnesium stearate; gelatin; brilliant scarlet 4r; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; allura red ac; povidone; sodium hydroxide - rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivastigmine hydrogen tartrate, quantity: 2.4 mg (equivalent: rivastigmine, qty 1.5 mg) - capsule, hard - excipient ingredients: sunset yellow fcf; titanium dioxide; microcrystalline cellulose; iron oxide yellow; sodium lauryl sulfate; gelatin; hypromellose; magnesium stearate; colloidal anhydrous silica; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; allura red ac; povidone; sodium hydroxide - rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type.

Канада - английский - Health Canada

dr reddy's laboratories ltd - rivastigmine (rivastigmine hydrogen tartrate) - capsule - 1.5mg - rivastigmine (rivastigmine hydrogen tartrate) 1.5mg - parasympathomemetic (cholinergic) agents

Канада - английский - Health Canada

dr reddy's laboratories ltd - rivastigmine (rivastigmine hydrogen tartrate) - capsule - 3.0mg - rivastigmine (rivastigmine hydrogen tartrate) 3.0mg - parasympathomemetic (cholinergic) agents

Канада - английский - Health Canada

dr reddy's laboratories ltd - rivastigmine (rivastigmine hydrogen tartrate) - capsule - 4.5mg - rivastigmine (rivastigmine hydrogen tartrate) 4.5mg - parasympathomemetic (cholinergic) agents